Drug intelligence / Profile preview

red watermelon extract

Development stage
Preclinical
Modality
Small Molecules
Administration
Oral
01

Overview

Red watermelon extract is a natural substance derived from the pulp of red-fleshed watermelon (Citrullus lanatus), containing a mixture of bioactive compounds, predominantly lycopene, L-citrulline, vitamins A (retinol), C (ascorbic acid), and E (α-tocopherol)[1][3]. It displays antioxidant, anti-inflammatory, and cardioprotective actions. The lycopene component can decrease the expression of pro-atherogenic proteins (e.g., PCSK9) and suppress oxidative stress and NF-κB signaling, thereby reducing inflammatory markers including TNF-α[3]. L-citrulline serves as a precursor for L-arginine and nitric oxide, supporting vascular health by promoting vasodilation and lowering blood pressure[7]. Combined, these components contribute to lowering LDL cholesterol, improving endothelial function, and potentially reducing the risk of atherosclerosis[3]. Red watermelon extract is not a single compound, drug, or pharmaceutical, but a natural multicomponent extract primarily investigated as a dietary supplement or functional food ingredient.

Other names
Citrullus lanatus red extractwatermelon pulp extractred watermelon fruit extract
02

Targets

NF-κBNOS1 (nNOS)

Beyond the preview

Go deeper on red watermelon extract.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on red watermelon extract.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call